Showing 521 - 540 results of 27,686 for search '(( 50 ((ms decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.94s Refine Results
  1. 521
  2. 522
  3. 523
  4. 524
  5. 525
  6. 526
  7. 527
  8. 528
  9. 529

    CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells. by Elif Aplak (7430123)

    Published 2020
    “…<p>A, 300 μM CNP (4 h) significantly decreased mitochondrial membrane potential in A375 cells, but not in melanocytes, indicated by changes of TMRM dependent fluorescence in mitochondria. …”
  10. 530
  11. 531
  12. 532
  13. 533

    The apparent Ca<sup>2+</sup> affinity of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

    Published 2020
    “…The significant rightward shift in the curve (EC50, non overlapping confidence intervals) indicates a decrease in the apparent Ca<sup>2+</sup> affinity of neurotransmitter release.…”
  14. 534
  15. 535
  16. 536
  17. 537
  18. 538
  19. 539

    Cellular proliferation is decreased in LV-shRNA-ADAMTS-1 transduced vessels. by Evelyn C. Nieves Torres (551495)

    Published 2014
    “…By day 7, there is a significant decrease in the mean Ki-67 index in the <b>LV</b> transduced vessels when compared to <b>C</b> at day 7 (P<0.01). …”
  20. 540

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”